Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001225208-18-008661)

Filing Details

Accession Number:: 0001225208-18-008661
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-05-03 16:19:16
Reporting Period:: 2018-05-01

Accepted Time:: 2018-05-03 16:19:16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1372915	C Ian Read	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2018-05-01	1,500	$36.05	1,275,515	No	4	S	Direct
Common Stock	Disposition	2018-05-01	3,700	$36.03	1,271,815	No	4	S	Direct
Common Stock	Disposition	2018-05-01	4,141	$36.04	1,267,674	No	4	S	Direct
Common Stock	Disposition	2018-05-01	14,600	$36.02	1,253,074	No	4	S	Direct
Common Stock	Disposition	2018-05-01	20,543	$36.01	1,232,531	No	4	S	Direct
Common Stock	Disposition	2018-05-01	87,828	$36.00	1,144,703	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	11,074	Indirect	By Rule 16b-3 Plan

Footnotes

This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018.